hailir(603639)
Search documents
海利尔:公司高度重视合规,持续把合规和可持续发展放在首位
Zheng Quan Ri Bao Wang· 2026-02-04 12:12
证券日报网讯2月4日,海利尔(603639)在互动平台回答投资者提问时表示,公司高度重视合规,持续 把合规和可持续发展放在首位,接下来将强化合规管理与人员培训。 ...
海利尔(603639) - 海利尔药业集团股份有限公司关于为全资子公司提供担保的进展公告
2026-01-23 08:30
证券代码:603639 证券简称:海利尔 公告编号:2026-001 海利尔药业集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 担 保 对 象一 被担保人名称 青岛凯源祥化工有限公司(以下简 称"凯源祥") 本次担保金额 10,000.00 万元 实际为其提供的担保余额 13,628.2 万元 是否在前期预计额度内 是 □否 □不适用:_________ 本次担保是否有反担保 □是 否 □不适用:_________ 担保对象及基本情况 累计担保情况 | 对外担保逾期的累计金额(万元) 0 | | | --- | --- | | 截至本公告日上市公司及其控股 子公司对外担保总额(万元) | 333,100 | | 对外担保总额占上市公司最近一 期经审计净资产的比例(%) | 97.29 | | 特别风险提示(如有请勾选) | □对外担保总额超过最近一期经审计净资产 100% | | | □担保金额超过上市公司最近一期经审计净 | | | 资产 50% | | ...
海利尔1月16日获融资买入320.67万元,融资余额9818.46万元
Xin Lang Cai Jing· 2026-01-19 01:31
截至9月30日,海利尔股东户数1.30万,较上期减少14.70%;人均流通股26229股,较上期增加17.23%。 2025年1月-9月,海利尔实现营业收入33.91亿元,同比增长5.50%;归母净利润2.08亿元,同比增长 6.15%。 分红方面,海利尔A股上市后累计派现12.55亿元。近三年,累计派现6.80亿元。 机构持仓方面,截止2025年9月30日,海利尔十大流通股东中,招商量化精选股票发起式A(001917) 位居第七大流通股东,持股272.15万股,为新进股东。香港中央结算有限公司位居第八大流通股东,持 股225.39万股,相比上期减少182.69万股。招商成长量化选股股票A(020901)位居第十大流通股东, 持股155.19万股,为新进股东。 责任编辑:小浪快报 1月16日,海利尔跌1.59%,成交额3244.57万元。两融数据显示,当日海利尔获融资买入额320.67万 元,融资偿还375.77万元,融资净买入-55.11万元。截至1月16日,海利尔融资融券余额合计9837.65万 元。 融资方面,海利尔当日融资买入320.67万元。当前融资余额9818.46万元,占流通市值的2.23%,融 ...
2026年中国丙硫菌唑行业发展现状、竞争格局、发展趋势研判:丙硫菌唑产能持续扩张,未来行业发展空间广阔[图]
Chan Ye Xin Xi Wang· 2026-01-17 23:24
Core Insights - The expiration of the compound patent for Pyraclostrobin in China has led to a surge in domestic interest, with companies increasing registration, production, and promotion efforts [1][6] - As of 2024, there are 62 registered Pyraclostrobin products in China, including 32 active ingredients and 30 formulations, primarily targeting wheat and peanut crops [1][6] - The global market for Pyraclostrobin has seen significant growth, with sales expected to rise from $973 million in 2015 to $2.014 billion by 2024, and projected to reach $2.172 billion by 2025 [5][11] Industry Overview - Pyraclostrobin, developed by Bayer in 2004, is a broad-spectrum fungicide known for its low toxicity and effectiveness against various plant diseases [2][3] - It is particularly effective against diseases affecting cereals and legumes, making it a key product in the global fungicide market, holding an 8% market share [3][5] Market Dynamics - The Chinese market for Pyraclostrobin is expanding rapidly due to the high incidence of wheat diseases, particularly Fusarium head blight, which can cause yield losses of 10% to 20% in epidemic years [7][11] - The area affected by Fusarium head blight in China is projected to reach 15 million acres in 2024, an increase of 6 million acres from 2023 [7][8] Competitive Landscape - Major companies in the Pyraclostrobin sector include Hailir, Anhui Jiuyi, Nantong Taihe, and Guangdong Guokang, among others, with many expanding production capacity [9][10] - Hailir reported a revenue of 3.391 billion yuan in the first nine months of 2025, a 5.5% increase year-on-year, indicating strong market performance [10] Future Trends - The demand for Pyraclostrobin is expected to continue rising due to increasing occurrences of wheat diseases and advancements in application methods [11] - The market is becoming increasingly competitive, with potential oversupply leading to price fluctuations, necessitating companies to optimize production and enhance brand presence [12] - The trend towards formulation mixtures is anticipated to grow, as combining Pyraclostrobin with other chemicals can delay resistance development and enhance efficacy [13]
海利尔1月6日获融资买入214.03万元,融资余额1.06亿元
Xin Lang Cai Jing· 2026-01-07 01:27
Group 1 - The core viewpoint of the news is that Hailir has shown significant trading activity and financial performance, with notable changes in financing and shareholder structure [1][2]. Group 2 - On January 6, Hailir's stock price increased by 0.86%, with a trading volume of 23.62 million yuan. The financing buy-in amount was 2.14 million yuan, while the financing repayment was 4.44 million yuan, resulting in a net financing buy of -2.30 million yuan [1]. - As of January 6, the total financing and securities lending balance for Hailir was 106 million yuan, with the financing balance accounting for 2.41% of the circulating market value, indicating a high level compared to the past year [1]. - Hailir's main business revenue composition includes 97.46% from pesticide formulations, 1.71% from fertilizers, 0.71% from agriculture and services, and 0.12% from other sources [1]. Group 3 - As of September 30, Hailir had 13,000 shareholders, a decrease of 14.70% from the previous period, while the average circulating shares per person increased by 17.23% to 26,229 shares [2]. - For the period from January to September 2025, Hailir achieved an operating income of 3.39 billion yuan, representing a year-on-year growth of 5.50%, and a net profit attributable to shareholders of 208 million yuan, up 6.15% year-on-year [2]. - Hailir has distributed a total of 1.255 billion yuan in dividends since its A-share listing, with 680 million yuan distributed over the past three years [2].
海利尔:发展规划和技术创新方向是解决作物痛点、提供高效解决方案
Zheng Quan Ri Bao Wang· 2025-12-29 13:42
证券日报网讯12月29日,海利尔(603639)在互动平台回答投资者提问时表示,发展规划和技术创新方 向是解决作物痛点、提供高效解决方案。 ...
海利尔:公司搭建“企业+政府+经销商+农业合作社+农户”一站式技术服务模式
Zheng Quan Ri Bao Wang· 2025-12-29 13:42
Group 1 - The company, Hailier (603639), emphasizes strengthening its R&D capabilities while continuously launching new technologies [1] - The company has served over one million farmers by building a professional team that understands agriculture and technology [1] - Hailier has established a one-stop technical service model involving "enterprise + government + distributors + agricultural cooperatives + farmers" to promote green pesticides and precision planting technologies [1]
海利尔:海利尔旗下明星肥料产品核心技术优势源于集团在农药领域积累的深厚研发实力与先进的精密检测
Zheng Quan Ri Bao Wang· 2025-12-29 13:42
Core Viewpoint - Hailier's flagship fertilizer products, "Sijiquanshi" and "JiaMeite," leverage the company's strong R&D capabilities in the pesticide sector, leading to significant differentiation in formulation design, process precision, and application effectiveness [1] Group 1 - Hailier emphasizes the innovative application of its deep R&D resources in pesticides to enhance fertilizer development and production [1] - The company highlights the technical synergy and quality control improvements achieved through this innovative approach [1] - The differentiated characteristics of its products contribute to maintaining a leading position in the market [1]
海利尔:公司有甲维盐产能
Zheng Quan Ri Bao Wang· 2025-12-29 13:42
Group 1 - The company, Hailier (603639), confirmed its production capacity for Methyl Acetate in response to investor inquiries on an interactive platform [1] - The company advised investors to refer to its regular reports for specific details regarding its production capacity [1]
海利尔:公司在AI农药领域的探索处于分阶段推进中
Zheng Quan Ri Bao Wang· 2025-12-29 13:42
Group 1 - The company, Hailier (603639), is exploring AI pesticide development in a phased manner [1] - The company has disclosed the number of shareholders in its periodic reports as per information disclosure requirements [1]